Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications.
Silence Therapeutics stock last closed at $3.70, up 8.82% from the previous day, and has decreased 83.07% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Silence Therapeutics stock is currently +87.82% from its 52-week low of $1.97, and -84.82% from its 52-week high of $24.38.
At the moment, there are 141.67M SLN shares outstanding. The market cap of SLN is $174.56M. In the last 24 hours, 132,882 SLN shares were traded.
How to Buy Silence Therapeutics Stock
Wondering how to invest in Silence Therapeutics stock? Here's how.
Choose where to buy Silence Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Silence Therapeutics stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Put funds into your brokerage account: Pick your payment method and add your info.
Analyze Silence Therapeutics stock: The Silence Therapeutics ticker symbol is SLN. Is Silence Therapeutics stock a good investment? Should you buy shares of SLN? How do SLN's underlying business fundamentals look? Do top analysts think Silence Therapeutics is a good buy? Why has SLN's stock price moved recently? (Hint: Our stock market research tools can help you figure out if SLN is a good stock to buy).
Execute your SLN buy order: Decide if you will purchase SLN shares at the current market price or use a limit order to purchase SLN shares at a particular price.
Track your investment in SLN: Create a watchlist to key updates about your position in Silence Therapeutics shares.
Step 1: Choose where to buy Silence Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy SLN shares.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in SLN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Silence Therapeutics stock
After you have identified the best place to buy Silence Therapeutics stock, it's crucial to research their stock before you invest, so you can understand the risk and opportunity.
Silence Therapeutics Numbers
SLN Price
$3.70
1w %
11.45%
1y %
-83.07%
5y %
N/A
P/E
-3.74x
P/B
-1.3x
P/S
3.96x
PEG
N/A
Revenue
$43.26M
Earnings
-$45.31M
Fore. Rev. Growth
61.09%
Fore. Earn. Growth
N/A
Market Cap
$174.56M
Next Earnings
N/A
Next Dividend
N/A
Silence Therapeutics Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on SLN's stock page.
Is SLN stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge SLN's true value.
Last year, SLN revenue was $43.26M. During the last 5 year, SLN's revenue has gone up by 169.37% per year. This was faster than the Biotechnology industry average of 45.66%.
No, Silence Therapeutics doesn't provide an income stream by paying out dividends.
SLN Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your SLN buy order
You have two primary options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open button and your broker will execute your order.
If you want additional help investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Silence Therapeutics share?
As of Apr 30, 2025, it costs $3.70 to buy one share of Silence Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.27 shares of SLN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.